https://www.avient.com/sites/default/files/2022-12/Mevopur Laser Marking Additives Application Bulletin.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
Processing conditions can cause material properties to shift from the values stated in the information.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2023-07/Avient_RY 2022 CDP Verification Opinion Declaration_07-24-23%5B30%5D.pdf
Microsoft Word - Avient_RY 2022 CDP Verification Opinion Declaration_07-24-23
WATER RESOURCES • ENVIRONMENTAL SERVICES • HEALTH & SAFETY • CLIMATE CHANGE
Apex Companies, LLC • (800) 733-2739 • www.apexcos.com
VERIFICATION OPINION DECLARATION
GREENHOUSE GAS EMISSIONS
To: The Stakeholders of Avient Corporation
Apex Companies, LLC (Apex) was engaged to conduct an independent verification of the greenhouse gas (GHG)
emissions reported by Avient Corporation (Avient) for the period stated below.
Level of Assurance and Qualifications:
Limited
This verification used a materiality threshold of ±5% for aggregate errors in sampled data for each of the
above indicators
GHG Verification Methodology:
Evidence-gathering procedures included, but were not limited to:
Interviews with relevant personnel of Avient and their consultant;
Review of documentary evidence produced by Avient;
Review of Avient data and information systems and methodology for collection, aggregation, analysis and
review of information used to determine GHG emissions; and
Audit of sample of data used by Avient to determine GHG emissions.
It is our opinion that Avient has established appropriate systems for the collection, aggregation and analysis of
quantitative data for determination of these GHG emissions for the stated period and boundaries.
https://www.avient.com/sites/default/files/2023-03/AvientRY 2021 CDP Verification Opinion Declaration_07-26-22r%5B96%5D.pdf
Microsoft Word - AvientRY 2021 CDP Verification Opinion Declaration_07-26-22r
WATER RESOURCES • ENVIRONMENTAL SERVICES • HEALTH & SAFETY • CLIMATE CHANGE
Apex Companies, LLC • (800) 733-2739 • www.apexcos.com
VERIFICATION OPINION DECLARATION
GREENHOUSE GAS EMISSIONS
To: The Stakeholders of Avient Corporation
Apex Companies, LLC (Apex) was engaged to conduct an independent verification of the greenhouse gas (GHG)
emissions reported by Avient Corporation (Avient) for the period stated below.
Level of Assurance and Qualifications:
Limited
This verification used a materiality threshold of ±5% for aggregate errors in sampled data for each of the
above indicators
GHG Verification Methodology:
Evidence-gathering procedures included, but were not limited to:
Interviews with relevant personnel of Avient and their consultant;
Review of documentary evidence produced by Avient;
Review of Avient data and information systems and methodology for collection, aggregation, analysis and
review of information used to determine GHG emissions; and
Audit of sample of data used by Avient to determine GHG emissions.
It is our opinion that Avient has established appropriate systems for the collection, aggregation and analysis of
quantitative data for determination of these GHG emissions for the stated period and boundaries.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives Chemical Foaming Agents Application Bulletin.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
Processing conditions can cause material properties to shift from the values stated in the information.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/industries/consumer/consumer-discretionary/computers-peripherals
Mobile Devices
Inhalation Devices
IVD Devices
https://www.avient.com/industries/telecommunications/5g-applications
Mobile Devices
Inhalation Devices
IVD Devices
https://www.avient.com/industries/energy/electronic-equipment
Mobile Devices
Inhalation Devices
IVD Devices
https://www.avient.com/industries/consumer/consumer-staples/everyday-essentials/apparel-footwear-accessories
Mobile Devices
Inhalation Devices
IVD Devices
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=26
Mevopur™ Colors and Functional Additives for In Vitro Diagnostic Devices - Application Bulletin
Benefits of using Mevopur™ Colors and Functional Additives for in vitro diagnostic devices
Medical Device Housing
https://www.avient.com/resource-center?document_type=59&page=26
Mevopur™ Colors and Functional Additives for In Vitro Diagnostic Devices - Application Bulletin
Benefits of using Mevopur™ Colors and Functional Additives for in vitro diagnostic devices
Medical Device Housing